Alpine Woods Capital Investors, LLC Ionis Pharmaceuticals Inc Transaction History

Alpine Woods Capital Investors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 07, 2020	SELL	$53.85 - $65.27 $285,405 - $345,931	-5,300 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$62.09 - $86.14 $329,077 - $456,542	5,300 New	5,300 $341,000

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.